The In Vitro Diagnostics (IVD) Market recorded stable and innovation-led growth in 2025, with the global market valued at USD 87.20 billion, supported by sustained demand for early disease detection, chronic disease monitoring, and decentralized diagnostic solutions. Test volumes remained strong across immunoassays, clinical chemistry, molecular diagnostics, hematology, and point-of-care testing, as healthcare systems in 2025 prioritized faster turnaround times, laboratory automation, and improved diagnostic accuracy. Reagents represented the largest product category, generating USD 58.81 billion in revenue during 2025, supported by recurring consumption across routine and specialized diagnostic procedures.
In Vitro Diagnostics (IVD) overview
Published by MMR Statistics Research Team, Updated
